HLA-G and ovarian cancer: However, ovarian cancer cells treated with differentiation agents showed a decrease in stemness and an increase in HLA-G and PD-L1 expression as a defense against anti-tumor immunity, indicating that the efficacy of combining differentiating drugs with chemotherapeutics might be unsatisfactory and the impact of immunosuppressive TME should be further explored [200].